SCOPUS 정보 검색 플랫폼

Volumn 23, Issue 4, 2002, Pages 508-516

II. Meta-analysis of alendronate for the treatment of postmenopausal women

(11) Cranney, Ann a Wells, George a Willan, Andrew a Griffith, Lauren a Zytaruk, Nicole a Robinson, Vivian a Black, Dennis a Adachi, Jonathan a Shea, Beverley a Tugwell, Peter a Guyatt, Gordon a

a MCMASTER UNIVERSITY (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; PLACEBO; VITAMIN D;

BONE DENSITY; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EMBASE; FEMALE; FRACTURE; GASTROINTESTINAL SYMPTOM; HIGH RISK POPULATION; HUMAN; MEASUREMENT; MEDLINE; META ANALYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCISEARCH; WORLD HEALTH ORGANIZATION; METABOLISM;

ALENDRONATE; BONE DENSITY; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS;

EID: 0036677983 PISSN: 0163769X EISSN: None Source Type: Journal
DOI: 10.1210/er.2001-2002 Document Type: Review

Times cited : (394)

References (29)

1
- 0028851590
- Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
- The Alendronate Phase III Osteoporosis Treatment Study Group
- (1995) N Engl J Med , vol.333 , pp. 1437-1443
- Liberman, U.A.¹ Weiss, S.R.² Broll³ Minne, H.W.⁴ Quan, H.⁵ Bell, N.H.⁶ Rodriguez-Portales, J.⁷ Downs, R.W.⁸ Dequeker, J.⁹ Favus, M.¹⁰ Seeman, E.¹¹ Recker, R.R.¹² Capizzi, T.¹³ Santora, A.C.¹⁴ Lombardi, A.¹⁵ Shah, R.V.¹⁶ Hirsch, L.J.¹⁷ Karpf, D.B.¹⁸

2
- 0031006598
- Prevention of non vertebral fractures by alendronate. A meta-analysis
- Alendronate Osteoporosis Treatment Study Groups
- (1997) JAMA , vol.277 , pp. 1159-1164
- Karpf, D.B.¹ Shapiro, D.R.² Seeman, E.³ Ensrud, K.E.⁴ Johnston, C.C.⁵ Adami, S.⁶ Harris, S.T.⁷ Santora A.C. II⁸ Hirsch, L.J.⁹ Oppenheimer, L.¹⁰ Thompson, D.¹¹

3
- 0004851872
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
- Fracture Intervention Trial Research Group
- (1996) Lancet , vol.348 , pp. 1535-1541
- Black, D.M.¹ Cummings, S.R.² Karpf, D.B.³ Cauley, J.A.⁴ Thompson, D.E.⁵ Nevitt, M.C.⁶ Bauer, D.C.⁷ Genant, H.K.⁸ Haskell, W.L.⁹ Marcus, R.¹⁰ Ott, S.M.¹¹ Tomer, J.A.¹² Quandt, S.A.¹³ Reiss, T.F.¹⁴ Ensrud, K.E.¹⁵

4
- 0027421874
- Preclinical pharmacology of alendronate
- (1993) Osteoporos Int , vol.3 , Issue.SUPPL. 3
- Rodan, G.A.¹ Seedor, J.G.² Balena, R.³

5
- 84863440810
- The Cochrane Library. The Cochrane Collaboration. Oxford, UK
- (1994) Cochrane Collaboration Handbook , Issue.4
- Mulrow, C.D.¹ Oxman, A.D.²

6
- 6844266291
- Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial
- Alendronate Osteoporosis Prevention Study Group
- (1998) Ann Intern Med , vol.128 , pp. 253-261
- McClung, M.¹ Clemmesen, B.² Daifotis, A.³ Gilchrist, N.L.⁴ Eisman, J.⁵ Weinstein, R.S.⁶ Fuleihan, G.E.⁷ Reda, C.⁸ Yates, J.A.⁹ Ravn, P.¹⁰

7
- 0346344235
- Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
- Early Postmenopausal Intervention Cohort Study Group
- (1998) N Engl J Med , vol.338 , pp. 485-492
- Hosking, D.¹ Chilvers, C.E.² Christiansen, C.³ Ravn, P.⁴ Washich, R.⁵ Ross, P.⁶ McClung, M.⁷ Balske, A.⁸ Thompson, D.⁹ Daley, M.¹⁰ Yates, J.A.¹¹

8
- 8044235628
- Dose-response relationships for alendronate treatment in osteoporotic elderly women
- Alendronate Elderly Osteoporosis Study Centers
- (1997) J Clin Endocrinol Metab , vol.82 , pp. 265-274
- Bone, H.G.¹ Downs R.W., Jr.² Tucci, J.R.³ Harris, S.T.⁴ Weinstein, R.S.⁵ Licata, A.A.⁶ McClung, M.R.⁷ Kimmel, D.B.⁸ Gertz, B.J.⁹ Polvino, W.J.¹⁰

9
- 0028846051
- Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis
- (1995) Bone , vol.17 , pp. 383-390
- Adami, S.¹ Passeri, M.² Ortolani, S.³ Broggini, M.⁴ Carratelli, L.⁵ Caruso, I.⁶ Gandolini, G.⁷ Gnessi, L.⁸ Laurenzi, M.⁹ Lombardi, A.¹⁰ Norbiato, G.¹¹ Pryor-Tillotson, S.P.¹² Reda, C.¹³ Romanini, L.¹⁴ Subrizi, D.¹⁵ Wei, L.¹⁶ Yates, J.A.¹⁷

10
- 0029116697
- Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling
- (1995) Am J Med , vol.99 , pp. 144-152
- Chesnut, C.H.¹ McClung, M.R.² Ensrud, K.E.³ Bell, N.H.⁴ Genant, H.K.⁵ Harris, S.T.⁶ Singer, F.R.⁷ Delmas, P.D.⁸ Kher, U.⁹ Pryor-Tillotson, S.¹⁰ Santora, A.C.¹¹

11
- 0031689775
- Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: A randomized clinical trial
- (1998) J Bone Miner Res , vol.13 , pp. 1431-1438
- Greenspan, S.L.¹ Parker, R.A.² Ferguson, L.³ Rosen, H.N.⁴ Maitland-Ramsey, L.⁵ Karpf, D.B.⁶

12
- 0032896590
- Multinational, placebo controlled, randomized trial of effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study
- (1999) Osteoporosis Int , vol.9 , pp. 461-468
- Pols, H.A.P.¹ Felsenberg, D.² Hanley, D.³ Stepan, J.⁴ Munoz-Torres, M.⁵ Wilkin, T.J.⁶ Qin-Sheng, G.⁷ Galich, A.M.⁸ Vandormael, K.⁹ Yates, J.A.¹⁰ Stych, B.¹¹

13
- 4243637276
- ASBMR-ISBM F280
- Alendronate vs. calcium for treatment of osteoporosis in postmenopausal women
- Bonnick, S.¹ Rosen, C.² Mako, B.³ DeLucca, P.⁴ Bymen, C.⁵ Melton, M.⁶

14
- 0032583492
- Alendronate reduces the risk of vertebral fractures in women without pre-existing vertebral fractures: Results of the Fracture Intervention trial
- (1998) JAMA , vol.280 , pp. 2077-2082
- Cummings, S.R.¹ Black, D.M.² Thompson, D.E.³ Applegate, W.B.⁴ Barrett-Connor, E.⁵ Musliner, T.A.⁶ Palermo, L.⁷ Prineas, R.⁸ Rubin, S.M.⁹ Scott, J.C.¹⁰ Vogt, T.¹¹ Wallace, R.¹² Yates, J.A.¹³ LaCroix, A.Z.¹⁴

15
- 0028541191
- Developing optimal search strategies for detecting clinically sound strategies in MEDLINE
- (1994) J Am Med Info Assoc , vol.1 , pp. 447-458
- Haynes, R.¹ Wilczynski, N.² McKibbon, K.A.³ Walker, C.J.⁴ Sinclair, J.C.⁵

16
- 0030278360
- Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
- (1996) Am J Med , vol.101 , pp. 488-501
- Tucci, J.R.¹ Tonino, R.P.² Emkey, R.D.³ Peverly, C.A.⁴ Kher, U.⁵ Santora, A.C.⁶

17
- 9044249713
- Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis
- (1996) Bone , vol.18 , pp. 141-150
- Devogelaer, J.P.¹ Broll, H.² Correa-Rotter, R.³ Cumming, D.C.⁴ Nagant De Deuxchaisnes, C.⁵ Geusens, P.⁶ Hosking, D.⁷ Jaeger, P.⁸ Kaufman, J.M.⁹ Leite, M.¹⁰ Leon, J.¹¹ Liberman, U.¹² Menkes, C.J.¹³ Meunier, P.J.¹⁴ Reid, I.¹⁵ Rodriguez, J.¹⁶ Romanowicz, A.¹⁷ Seeman, E.¹⁸ Vermeulen, A.¹⁹ Hirsch, L.J.²⁰ more..

18
- 0027453805
- Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin
- (1993) Osteoporosis Int , vol.3
- Adami, S.¹ Baroni, M.C.² Broggini, M.³ Carratelli, L.⁴ Caruso, I.⁵ Gnessi, L.⁶ Laurenzi, M.⁷ Lombardi, A.⁸ Norbiato, G.⁹ Ortolani, S.¹⁰ Ricerca, E.¹¹ Romanini, L.¹² Subrizi, S.¹³ Weinberg, J.¹⁴ Yates, J.A.¹⁵

19
- 0027754610
- The statistical basis of meta-analysis
- (1993) Stat Methods Med Res , vol.2 , pp. 121-145
- Fleiss, J.L.¹

20
- 0003583491
- San Diego: Academic Press
- (1985) Statistical methods for meta-analysis , pp. 159-165
- Hedges, L.V.¹ Olkin, I.²

21
- 0029561513
- Sustained response to intravenous alendronate in postmenopausal osteoporosis
- (1995) Bone , vol.17 , pp. 517-520
- Vasikaran, S.D.¹ Khan, S.² McCloskey, E.V.³ Kanis, J.A.⁴

22
- 0028119643
- Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis
- (1994) J Bone Miner Res , vol.9 , pp. 1833-1837
- Rossini, M.¹ Gatti, D.² Zamberlan, N.³ Braga, V.⁴ Dorizzi, R.⁵ Adami, S.⁶

23
- 0027322175
- The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women
- (1993) J Clin Endocrinol Metab , vol.76 , pp. 1399-1406
- Harris, S.T.¹ Gertz, B.J.² Genant, H.K.³ Eyre, D.R.⁴ Survill, T.T.⁵ Ventura, J.N.⁶ DeBrock, J.⁷ Ricerca, E.⁸ Chesnut C.H. III⁹

24
- 0027421875
- Short-term effect of alendronate on bone mass and bone remodeling in postmenopausal women
- (1993) Osteoporosis Int , vol.3
- Chesnut C.H. III¹ Harris, S.T.²

25
- 0030868816
- Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis
- (1997) J Clin Invest , vol.100 , pp. 1475-1480
- Chavassieux, P.M.¹ Arlot, M.E.² Reda, C.³ Wei, L.⁴ Yates, A.J.⁵ Meunier, P.J.⁶

26
- 0034530951
- Fracture risk reduction with alendronate in women with osteoporosis: The fracture intervention trial
- (2000) J Clin Endocrinol Metab , vol.85 , pp. 4118-4124
- Black, D.M.¹ Thompson, D.E.² Bauer, D.C.³ Ensrud, K.⁴ Musliner, M.C.⁵ Hochberg, M.C.⁶ Nevitt, M.C.⁷ Suryawanshi, S.⁸ Cummings, S.R.⁹

27
- 0035253489
- Effect of risedronate on the risk of hip fracture in elderly women
- (2001) N Engl J Med , vol.344 , pp. 333-340
- McClung, M.¹ Geusens, P.² Miller, P.³ Zippel, H.⁴ Bensen, W.G.⁵ Roux, C.⁶ Adami, S.⁷ Fogelman, I.⁸ Diamond, T.⁹ Eastell, R.¹⁰ Meunier, P.J.¹¹ Reginster, J.Y.¹²

28
- 0033552255
- Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis
- (1999) J Am Med Assoc , vol.282 , pp. 1344-1352
- Harris, S.T.¹ Watts, M.B.² Genant, H.K.³ McKeever, C.D.⁴ Hangartner, T.⁵ Keller, M.⁶ Chesnut, C.H.⁷ Brown, J.⁸ Eriksen, E.F.⁹ Hoseyni, M.S.¹⁰ Axelrod, D.W.¹¹ Miller, P.¹²

29
- 0025997976
- Which fractures are associated with low appendicular mass in elderly women?
- (1991) Ann Intern Med , vol.115 , pp. 837-842
- Seeley, D.G.¹ Browner, W.S.² Nevitt, M.C.³ Genant, H.K.⁴ Scott, J.C.⁵ Cummings, S.R.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.